Adam D. Cutler Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

NAVB Quotes by TradingView

Adam D. Cutler is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 10,000 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Jan 13, 2021, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $0

Adam D. Cutler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 13 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 20.0%
10,000 Common Stock

Also insider at

INM
InMed Pharmaceuticals Inc. Healthcare
Director
MTEM
Molecular Templates, Inc. Healthcare
Officer
MURA
Mural Oncology plc
Chief Financial Officer
ADC

Adam D. Cutler

Director
Vancouver, A1

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAVB